Navamedic ASA: Q2 2018 results
Oslo, August 24, 2018 - Navamedic ASA (OSE: NAVA) reported revenues of NOK 45.2 million in the second quarter of 2018, down from NOK 89.7 million in the same period in 2017, following the planned discontinuation of the Aspen agreement. The company significantly strengthened the gross margin to 35%, compared to 22.7% in the same quarter last year, reflecting growth in higher margin products. Sippi® wireless connectivity to Patient Data Monitoring Systems (PDMS) was completed during the quarter, with a solid test backlog of hospitals across Europe. "The second quarter of 2018 marks